Nanjing, China

Lin Li

This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Nanjing Transthera Biosciences Co. Ltd., Transthera Sciences (Nanjing), Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lin Li. Retrieved from https://idiyas.com/inventor/lin-li-9le9rm8i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lin Li: A Prominent Figure in Medical Research

Introduction

Lin Li, based in China, has made significant contributions to the medical field. While he holds no patents to his name, his work in esteemed institutions has been noteworthy.

Latest Patents

Currently, Lin Li does not hold any patents. However, his efforts in research and collaboration continue to impact the medical community positively.

Career Highlights

Lin Li has worked with prominent organizations such as the Chinese Academy of Medical Sciences and Xuanwu Hospital of Capital Medical University. His experience in these institutions has allowed him to engage deeply with advanced medical research and clinical practices.

Collaborations

Lin Li has collaborated with Cuiping Zhou, demonstrating a teamwork approach in their research endeavors. This partnership illustrates the importance of collaboration in advancing medical science.

Conclusion

Even without patents, Lin Li has proven to be a valuable asset to the medical research community through his work and collaborations. His contributions continue to shape the landscape of medical science in China.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…